Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA
Clinical trial NCT03119701 · TERMINATED
Trial details
- NCT number
- NCT03119701
- Sponsor
- Faron Pharmaceuticals Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-18
- Primary completion
- 2019-09-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.